
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-633-5555
Fax+1 469-291-2736
Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
- Washington University in St. Louis School of MedicineClass of 2006
- Cornell UniversityB.A., Biology, Concentration in Biochemistry, 2001
Certifications & Licensure
- TX State Medical License 2018 - 2026
- NY State Medical License 2009 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Tito Bastianello Young Investigator Award MDS Foundation, 2017
- Paul Sherlock Housestaff Teaching Award, Department of Medicine MSKCC, 2017
- Early Career Award in Myelodysplastic Syndrome Research Dresner Foundation, 2017
- Join now to see all
Publications & Presentations
PubMed
- Imatinib-Induced Clinical Response in ETV6::ACSL6 Myeloid Neoplasm with Eosinophilic Pneumonitis: A Case Report.Fieke W Hoff, Sharon Germans, Olga K Weinberg, Robert H Collins Jr, Rolando García
The American Journal of Case Reports. 2025-04-09 - CD44-mediated metabolic rewiring is a targetable dependency of IDH-mutant leukemia.Junhua Lyu, Yuxuan Liu, Ningning Liu, Hieu S Vu, Feng Cai
Blood. 2025-04-03 - 1 citationsNonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants.Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, Bo Shen, Xiang Gao
Cancer Discovery. 2025-04-02
Journal Articles
- CD99 is a Therapeutic Target on Disease Stem Cells in Myeloid MalignanciesChung SS, Eng WS, Hu W, Khalaj M, Garrett-Bakelman FE, Tavakkoli M, Levine RL, Carroll M, Klimek VM, Melnick AM, Park CY, Sci Transl Med, 1/1/2017
- MicroRNA Dysregulation in the Myelodysplastic SyndromesChung SS, Park CY, MicroRNA, 1/1/2013
- A 75- year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)Baikaidi M, Chung SS, Tallman MS, Damon LE, Walker AR, Marcucci G, Sholi AM, Morris GJ, Semin Oncol, 1/1/2012
- Join now to see all
Books/Book Chapters
Lectures
- An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution.1/1/2017
- An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution. Session 636. Myelodysplastic Syndromes- Basic...1/1/2016
- CD99 is a Therapeutic Target on Disease Stem Cells in the Myelodysplastic Syndromes and Acute Myeloid Leukemia. Session 6: The Myelodysplastic Syndromes.1/1/2014
- Join now to see all
Press Mentions
- CRI Scientists Link Hematopoietic Cell Transplant Deaths to Beta-Blocker UseDecember 30th, 2024
- Breakthrough Research Studies Are Unveiled at the MDS Foundation 14th International Symposium on Myelodysplastic SyndromesMay 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: